Lélia E.
- Country
- France
- Department
- Maladies infectieuses - Equipe mobile d’antibiothérapie
Research Overview
- Non‑inferiority of oral fosfomycin versus fluoroquinolone or TMP‑SMX combination therapy as step‑down treatment for febrile urinary tract infection in men caused by Escherichia coli
- Evaluation of Customized Antibiotic Treatment Duration in Hospitalized Patients with Moderately Severe Community-Acquired Pneumonia Using Pristinamycin and Drug Combination
- Evaluation of Intravenous Dalbavancin Versus Standard Antibiotic Regimen in Staphylococcus aureus Catheter-Related Bloodstream Infections
Data & Insights
Has run more than one trial at 38 of 140 partner sites.
Specializations
Infection Control & Antimicrobial Management
The investigator specializes in developing innovative approaches for managing multi-drug resistant gram-negative bacteria (MDR-GNB) colonization, including the application of fecal microbiota transplantation techniques.
- Bacterial Decolonization Strategies
- Microbiome-Based Interventions
- Antimicrobial Resistance Management
Their work focuses on establishing effective protocols for addressing antibiotic-resistant bacterial colonization.
Bloodstream Infections
The investigator conducts research in the treatment of catheter-related bloodstream infections, particularly those caused by Staphylococcus aureus, exploring novel antibiotic administration approaches.
- Catheter-Related Infections
- Antibiotic Therapy Optimization
- Staphylococcal Infections
Their research evaluates innovative treatment regimens using long-acting antibiotics for bloodstream infections.
Neurological Infections
The investigator explores treatment strategies for bacterial brain abscess, investigating the efficacy of oral versus intravenous antibiotic therapies in neurological infections.
- Brain Abscess Management
- Antibiotic Delivery Methods
- Neurological Infection Outcomes
Their work aims to optimize antibiotic administration routes for central nervous system infections.
Respiratory Infections
The investigator studies optimized treatment approaches for community-acquired pneumonia, focusing on customized antibiotic duration strategies for hospitalized patients.
- Pneumonia Treatment Protocols
- Antibiotic Duration Optimization
- Clinical Stability Assessment
Their research emphasizes evidence-based approaches to antibiotic treatment duration in respiratory infections.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.